Mitchell Levine

Mitchell Levine

Chairman presso IMMUNOPRECISE ANTIBODIES LTD.

Patrimonio netto: 30 400 $ in data 31/03/2024

Finance
Health Technology
Consumer Services

Profilo

Mitchell Stuart Levine is the founder of Enable Global Capital LLC, which was founded in 2002.
He held the title of Managing Member & Chief Compliance Officer at Enable Global Capital LLC from 2011 to 2017.
Mr. Levine is currently the Chairman & Chief Executive Officer at Smart Health Diagnostics Co. since 2022 and the Chairman at ImmunoPrecise Antibodies Ltd.
since 2023.
Mr. Levine has held former positions as Principal at Bear, Stearns & Co., Inc., Principal at Lehman Brothers Distressed Structured Credit Capital Partners, Principal at The Shemano Group, Inc., Managing Partner at Cove Capital Advisors, Inc., and Chief Financial Officer at OncoCyte Corp.
from 2017 to 2022.
Mr. Levine obtained his undergraduate degree from the University of California, Davis.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
21/03/2024 20 000 ( 0.08% ) 30 400 $ 31/03/2024

Posizioni attive di Mitchell Levine

SocietàPosizioneInizio
IMMUNOPRECISE ANTIBODIES LTD. Chairman 27/11/2023
Chief Executive Officer 01/11/2022
Tutte le posizioni attive di Mitchell Levine

Precedenti posizioni note di Mitchell Levine

SocietàPosizioneFine
Founder 01/01/2017
Cove Capital Advisors, Inc. Corporate Officer/Principal -
ONCOCYTE CORPORATION Director of Finance/CFO 01/06/2022
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal -
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mitchell Levine

Formazione di Mitchell Levine

University of California, Davis Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Mitchell Levine

Relazioni

18

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Aziende private6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Mitchell Levine